{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,16]],"date-time":"2026-03-16T04:50:18Z","timestamp":1773636618552,"version":"3.50.1"},"reference-count":35,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100006458","name":"Children's Hospital of Philadelphia","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006458","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100030656","name":"Department of Radiology, Baylor College of Medicine","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100030656","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","pet.theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["PET Clinics"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1016\/j.cpet.2025.11.001","type":"journal-article","created":{"date-parts":[[2026,1,14]],"date-time":"2026-01-14T21:09:00Z","timestamp":1768424940000},"page":"321-330","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Evaluation of Congenital Hyperinsulinism Using 18F-FDOPA PET"],"prefix":"10.1016","volume":"21","author":[{"given":"Lisa J.","family":"States","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter","family":"Francis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eva R.","family":"Hamel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Susan A.","family":"Becker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Diva D.","family":"De Leon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"9","key":"10.1016\/j.cpet.2025.11.001_bib1","doi-asserted-by":"crossref","first-page":"e1787","DOI":"10.1210\/clinem\/dgae267","article-title":"Approach to the neonate with hypoglycemia","volume":"109","author":"Lord","year":"2024","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"10.1016\/j.cpet.2025.11.001_bib2","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1002\/ajmg.c.31737","article-title":"Congenital hyperinsulinism disorders: genetic and clinical characteristics","volume":"181","author":"Rosenfeld","year":"2019","journal-title":"Am J Med Genet C Semin Med Genet"},{"key":"10.1016\/j.cpet.2025.11.001_bib3","first-page":"1","article-title":"The birth prevalence of congenital hyperinsulinism: a narrative review of the epidemiology of a rare disease","author":"Lapidus","year":"2024","journal-title":"Horm Res Paediatr"},{"issue":"3","key":"10.1016\/j.cpet.2025.11.001_bib4","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1159\/000531766","article-title":"International guidelines for the diagnosis and management of hyperinsulinism","volume":"97","author":"De Leon","year":"2024","journal-title":"Horm Res Paediatr"},{"issue":"12","key":"10.1016\/j.cpet.2025.11.001_bib5","doi-asserted-by":"crossref","first-page":"4941","DOI":"10.1210\/jc.2008-0673","article-title":"Chromosome 11p15 paternal isodisomy in focal forms of neonatal hyperinsulinism","volume":"93","author":"Damaj","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"10.1016\/j.cpet.2025.11.001_bib6","doi-asserted-by":"crossref","first-page":"E355","DOI":"10.1210\/jc.2012-2169","article-title":"Genotype and phenotype correlations in 417 children with congenital hyperinsulinism","volume":"98","author":"Snider","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.cpet.2025.11.001_bib7","doi-asserted-by":"crossref","DOI":"10.3389\/fped.2023.1071206","article-title":"New approaches to screening and management of neonatal hypoglycemia based on improved understanding of the molecular mechanism of hypoglycemia","volume":"11","author":"Stanley","year":"2023","journal-title":"Front Pediatr"},{"issue":"2","key":"10.1016\/j.cpet.2025.11.001_bib8","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1007\/s00259-017-3867-1","article-title":"18F-DOPA PET\/CT and 68Ga-DOTANOC PET\/CT scans as diagnostic tools in focal congenital hyperinsulinism: a blinded evaluation","volume":"45","author":"Christiansen","year":"2018","journal-title":"Eur J Nucl Med Mol Imag"},{"issue":"2","key":"10.1016\/j.cpet.2025.11.001_bib9","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1016\/j.jpedsurg.2012.11.025","article-title":"Accuracy of PET\/CT scan in the diagnosis of the focal form of congenital hyperinsulinism","volume":"48","author":"Laje","year":"2013","journal-title":"J Pediatr Surg"},{"issue":"3","key":"10.1016\/j.cpet.2025.11.001_bib10","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1210\/jc.2007-2036","article-title":"Evaluation of [18F]fluoro-L-DOPA positron emission tomography-computed tomography for surgery in focal congenital hyperinsulinism","volume":"93","author":"Barthlen","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"issue":"12","key":"10.1016\/j.cpet.2025.11.001_bib11","doi-asserted-by":"crossref","first-page":"2120","DOI":"10.1007\/s00259-007-0498-y","article-title":"The added value of [18F]fluoro-L-DOPA PET in the diagnosis of hyperinsulinism of infancy: a retrospective study involving 49 children","volume":"34","author":"Ribeiro","year":"2007","journal-title":"Eur J Nucl Med Mol Imag"},{"issue":"4","key":"10.1016\/j.cpet.2025.11.001_bib12","first-page":"560","article-title":"Characterization of hyperinsulinism in infancy assessed with PET and 18F-fluoro-L-DOPA","volume":"46","author":"Ribeiro","year":"2005","journal-title":"J Nucl Med"},{"issue":"1","key":"10.1016\/j.cpet.2025.11.001_bib13","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1210\/jc.2003-030965","article-title":"Preoperative evaluation of infants with focal or diffuse congenital hyperinsulinism by intravenous acute insulin response tests and selective pancreatic arterial calcium stimulation","volume":"89","author":"Stanley","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"10.1016\/j.cpet.2025.11.001_bib14","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1007\/s11307-012-0572-0","article-title":"The value of radiologic interventions and (18)F-DOPA PET in diagnosing and localizing focal congenital hyperinsulinism: systematic review and meta-analysis","volume":"15","author":"Blomberg","year":"2013","journal-title":"Mol Imag Biol"},{"issue":"Suppl 2","key":"10.1016\/j.cpet.2025.11.001_bib15","doi-asserted-by":"crossref","first-page":"51S","DOI":"10.2967\/jnumed.120.246033","article-title":"18F-6-Fluoro-l-Dopa PET\/CT imaging of congenital hyperinsulinism","volume":"62","author":"States","year":"2021","journal-title":"J Nucl Med"},{"issue":"1","key":"10.1016\/j.cpet.2025.11.001_bib16","doi-asserted-by":"crossref","first-page":"112","DOI":"10.2967\/jnumed.119.228627","article-title":"PET-based human dosimetry of 68Ga-NODAGA-Exendin-4, a tracer for \u03b2-Cell imaging","volume":"61","author":"Boss","year":"2020","journal-title":"J Nucl Med"},{"issue":"2","key":"10.1016\/j.cpet.2025.11.001_bib17","doi-asserted-by":"crossref","first-page":"310","DOI":"10.2967\/jnumed.121.262327","article-title":"68Ga-NODAGA-Exendin-4 PET\/CT improves the detection of focal congenital hyperinsulinism","volume":"63","author":"Boss","year":"2022","journal-title":"J Nucl Med"},{"issue":"11","key":"10.1016\/j.cpet.2025.11.001_bib18","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0186340","article-title":"Pancreatic uptake and radiation dosimetry of 6-[18F]fluoro-L-DOPA from PET imaging studies in infants with congenital hyperinsulinism","volume":"12","author":"Garg","year":"2017","journal-title":"PLoS One"},{"issue":"6","key":"10.1016\/j.cpet.2025.11.001_bib19","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1097\/MNM.0b013e32836069d0","article-title":"18F-DOPA PET and enhanced CT imaging for congenital hyperinsulinism: initial UK experience from a technologist\u2019s perspective","volume":"34","author":"Meintjes","year":"2013","journal-title":"Nucl Med Commun"},{"issue":"3","key":"10.1016\/j.cpet.2025.11.001_bib20","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1097\/ALN.0000000000001452","volume":"126","year":"2017","journal-title":"Anesthesiology"},{"issue":"7","key":"10.1016\/j.cpet.2025.11.001_bib21","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1111\/j.1460-9592.2007.02192.x","article-title":"Congenital hyperinsulinism - a review of the disorder and a discussion of the anesthesia management","volume":"17","author":"Hardy","year":"2007","journal-title":"Paediatr Anaesth"},{"issue":"1","key":"10.1016\/j.cpet.2025.11.001_bib22","doi-asserted-by":"crossref","first-page":"13","DOI":"10.2337\/diabetes.55.01.06.db05-1128","article-title":"Noninvasive diagnosis of focal hyperinsulinism of infancy with [18F]-DOPA positron emission tomography","volume":"55","author":"Otonkoski","year":"2006","journal-title":"Diabetes"},{"issue":"12","key":"10.1016\/j.cpet.2025.11.001_bib23","doi-asserted-by":"crossref","first-page":"2511","DOI":"10.1016\/j.jpedsurg.2013.05.016","article-title":"Pancreatic surgery in infants with Beckwith-Wiedemann syndrome and hyperinsulinism","volume":"48","author":"Laje","year":"2013","journal-title":"J Pediatr Surg"},{"issue":"6","key":"10.1016\/j.cpet.2025.11.001_bib24","doi-asserted-by":"crossref","DOI":"10.1210\/jendso\/bvac056","article-title":"Correlation of PET-MRI, pathology, LOH, and surgical success in a case of CHI with atypical large pancreatic focus","volume":"6","author":"Vossschulte","year":"2022","journal-title":"J Endocr Soc"},{"issue":"1","key":"10.1016\/j.cpet.2025.11.001_bib25","first-page":"40","article-title":"Proposal for a standardized protocol for 18F-DOPA-PET (PET\/CT) in congenital hyperinsulinism","volume":"66","author":"Mohnike","year":"2006","journal-title":"Horm Res"},{"issue":"1","key":"10.1016\/j.cpet.2025.11.001_bib26","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.jpedsurg.2018.10.030","article-title":"Surgical treatment of congenital hyperinsulinism: results from 500 pancreatectomies in neonates and children","volume":"54","author":"Adzick","year":"2019","journal-title":"J Pediatr Surg"},{"issue":"10","key":"10.1016\/j.cpet.2025.11.001_bib27","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0241243","article-title":"Visual interpretation, not SUV ratios, is the ideal method to interpret 18F-DOPA PET scans to aid in the cure of patients with focal congenital hyperinsulinism","volume":"15","author":"Garg","year":"2020","journal-title":"PLoS One"},{"key":"10.1016\/j.cpet.2025.11.001_bib28","doi-asserted-by":"crossref","DOI":"10.3389\/fped.2021.699129","article-title":"Case report: two distinct focal congenital hyperinsulinism lesions resulting from separate genetic events","volume":"9","author":"Rosenfeld","year":"2021","journal-title":"Front Pediatr"},{"issue":"1","key":"10.1016\/j.cpet.2025.11.001_bib29","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/j.jpedsurg.2006.09.046","article-title":"Multiple ectopic lesions of focal islet adenomatosis identified by positron emission tomography scan in an infant with congenital hyperinsulinism","volume":"42","author":"Peranteau","year":"2007","journal-title":"J Pediatr Surg"},{"issue":"1","key":"10.1016\/j.cpet.2025.11.001_bib30","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.jpedsurg.2011.10.032","article-title":"Pancreatic head resection and Roux-en-Y pancreaticojejunostomy for the treatment of the focal form of congenital hyperinsulinism","volume":"47","author":"Laje","year":"2012","journal-title":"J Pediatr Surg"},{"key":"10.1016\/j.cpet.2025.11.001_bib31","unstructured":"States L, Utility of [18F] fluoroDOPA for neonatal hyperinsulinism, 2022, National Library of Medicine, Available at: Clinicaltrials.gov."},{"key":"10.1016\/j.cpet.2025.11.001_bib32","series-title":"Phase II safety and efficacy study of 18FDOPA PET-CT in children with hyperinsulinemic hypoglycemia (18FDOPA)","author":"States","year":"2022"},{"issue":"spe","key":"10.1016\/j.cpet.2025.11.001_bib33","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1590\/S1516-89132007000600009","article-title":"FDOPA-(18F): a PET radiopharmaceutical recently registered for diagnostic use in countries of the european union","volume":"50","author":"Chevalme","year":"2007","journal-title":"Braz Arch Biol Technol"},{"issue":"3","key":"10.1016\/j.cpet.2025.11.001_bib34","article-title":"FDA reviews NDA for 18F-FDOPA in congenital hyperinsulinism","volume":"60","year":"2019","journal-title":"J Nucl Med"},{"key":"10.1016\/j.cpet.2025.11.001_bib35","unstructured":"FDA approves drug to treat Parkinson\u2019s disease, Available at: https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2019\/200655s000lbl.pdf."}],"container-title":["PET Clinics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1556859825001154?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1556859825001154?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,16]],"date-time":"2026-03-16T03:52:43Z","timestamp":1773633163000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1556859825001154"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4]]},"references-count":35,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,4]]}},"alternative-id":["S1556859825001154"],"URL":"https:\/\/doi.org\/10.1016\/j.cpet.2025.11.001","relation":{},"ISSN":["1556-8598"],"issn-type":[{"value":"1556-8598","type":"print"}],"subject":[],"published":{"date-parts":[[2026,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Evaluation of Congenital Hyperinsulinism Using 18F-FDOPA PET","name":"articletitle","label":"Article Title"},{"value":"PET Clinics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cpet.2025.11.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}